The Cost of Delaying A Trial
12 April 2021
From discovery and development through to market, the life cycle of new medicine is a profoundly complex process, frequently met with obstacles. Research produced by PhRMA found that clinical trials take on average six to seven years to assess safety and efficiency, with the overall probability of success less than 12%[1]. The extensive timeline of these trials......
New Zealand: A Promising Destination For Trials in A Post-Covid-19 World?
18 December 2020
Unlike the rest of the world, New Zealand’s speedy and decisive response to Covid-19 has successfully enabled the country’s clinical trials to continue largely unscathed. Allie Nawrat talks to key actors in the New Zealand clinical space about how Covid-1...
Successful Patient Recruitment In a COVID-19 World
03 December 2020
Pharmaceutical Solutions (PSL), which is New Zealand and Australia-based, has been geographically fortunate, and our proven strategies have also ensured the continuation and success of our clinical studies. ...
Rapid Study Startup and High Patient Recruitment for US Biotech Clinical Trial
01 December 2020
A US-based biotech company was seeking a CRO who could successfully recruit a large number of elderly patients in New Zealand. A challenge squeezed into a three-month recruitment window....
Pharmaceutical Solutions: Quality Assurance in Clinical Trials
15 October 2020
With international travel restrictions in place, many pharmaceutical/biotech/CRO companies have had to place quality assurance audits for their clinical trials on hold. ...
Assured Continuity of Clinical Trials in Australia and New Zealand during the Covid-19 pandemic
09 October 2020
Confidence in the Australian and New Zealand clinical environment has been shown globally with 170 new study start-ups registered on the ANZCTR between April and August 2019....
Clinical trial continuity in NZ: Optimal Clinical Trials.
17 August 2020
Clinical trials are considered an essential service by the New Zealand Government and so can continue to operate at all alert levels....
Clinical trials in NZ worth $1.2 billion: Medicines NZ
21 May 2020
Chief executive of Medicines NZ, Graeme Jarvis, says there has to be a collaborative effort between the industry, clinical research sector and government ...
Medicines NZ report estimates clinical trials worth $1.2b over 5 years
20 May 2020
Clinical trail prescription medicines have contributed at least $1.2 billion to the New Zealand economy since 2013...
Business Continuity during COVID-19
21 April 2020
COVID-19 restrictions have not impacted our ability to support trial start-up, feasibility, ethics, and regulatory in New Zealand and Australia....
Business Continuity during Covid19
31 March 2020
Jacquie Palmer Managing Director details strategic support and focuses for the next 8 weeks....
The Advantages of working with an Independent CRO in Australia and New Zealand.
19 July 2019
Tap into 20 years of Clinical Research experience with PSL...